Kodiak Sciences (KOD) Amortizatization of Intangibles (2019 - 2026)
Kodiak Sciences' (KOD) quarterly Amortizatization of Intangibles came in at $328000.0 in Q2 2023, up 4.46% YoY from $314000.0 in Q2 2022, and down 36.68% on a QoQ basis from $518000.0 in Q1 2023.
Analysis
Kodiak Sciences (KOD) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 5 years of Amortizatization of Intangibles data on file, last reported at $328000.0 in Q2 2023.
- Quarterly Amortizatization of Intangibles rose 4.46% year-over-year to $328000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $328000.0 (down 79.32% YoY) and the FY2023 annual result came in at $846000.0, down 20.79% from the prior year.
- Amortizatization of Intangibles fell to $328000.0 in Q2 2023, from $518000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $518000.0 in Q1 2023 to a low of -$356000.0 in Q2 2020.
- A 5-year average of $145400.0 and a median of $100000.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2020 — Amortizatization of Intangibles slumped 456.0% — and 2022, when it soared 5333.33%.
- Tracing KOD's Amortizatization of Intangibles over 5 years: stood at $46000.0 in 2019, then tumbled by 304.35% to -$94000.0 in 2020, then jumped by 93.62% to -$6000.0 in 2021, then jumped by 5433.33% to $320000.0 in 2022, then increased by 2.5% to $328000.0 in 2023.
- The last three Amortizatization of Intangibles figures came in at $328000.0 (Q2 2023), $518000.0 (Q1 2023), and $320000.0 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | 2.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.99 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.84 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 1.91 Mn |